Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted December 5, 2015
Lipo Escultura Weight Loss Capsules Recalled
Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.
Diclofenac is a non-steroid anti-inflammatory drug (NSAID), which can increase the risk of cardiovascular events and gastrointestinal damage, such as bleeding, ulceration, and fatal perforation of the stomach.
Recalled Lipo Escultura capsules are white, and packaged in a white plastic bottle with green and lime labeling. They were sold nationwide through online sales at www.lipoesculturatreatment.com and in Lipo Escultura Corp retail stores in Brooklyn NY.
Consumers who have purchased this supplement should discontinue use and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.
See ConsumerLab.com's Review of Weight Loss Supplements for tests of related products.
See Related Warnings:
For more about the recall, use the link below.